2005
DOI: 10.1159/000088333
|View full text |Cite
|
Sign up to set email alerts
|

Primary Breast Lymphoma: Results of a Controlled Clinical Trial

Abstract: Objectives: To assess the efficacy and toxicity of the most employed therapeutic approaches in the treatment of primary breast lymphoma (PBL). Methods: Ninety-six patients with PBL in the early stage (I or II) were enrolled to receive radiotherapy (45 Gy); chemotherapy (six cycles of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP), every 21 days), or combined therapy. Results: Complete response was achieved in 20 of 30 patients treated with radiotherapy, 19 of 32 who were treated with chemothe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

21
215
4
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(241 citation statements)
references
References 25 publications
(22 reference statements)
21
215
4
1
Order By: Relevance
“…It can suggest itself as a primary breast tumor or as an extranodal expression in systemic disease. Since extranodal manifestation is more familiar in non-Hodgkin's lymphoma (NHL) than Hodgkin's disease (HD), with NHLs covering the majority of PBLs [3,4]. Secondary BL (SBL) is more common.…”
Section: Introductionmentioning
confidence: 99%
“…It can suggest itself as a primary breast tumor or as an extranodal expression in systemic disease. Since extranodal manifestation is more familiar in non-Hodgkin's lymphoma (NHL) than Hodgkin's disease (HD), with NHLs covering the majority of PBLs [3,4]. Secondary BL (SBL) is more common.…”
Section: Introductionmentioning
confidence: 99%
“…However, assessment of the association between treatment type and survival was limited due to the retrospective nature of the present study and the limited number of patients included. The only randomized comparison to date demonstrated a significantly improved survival rate in patients who received combined chemotherapy and radiotherapy, compared with chemotherapy or radiotherapy alone (24). In the present study, one patient, who presented with bilateral breast involvement, developed a relapse of the left breast following a lumpectomy and chemotherapy.…”
Section: Discussionmentioning
confidence: 44%
“…These patients belonged to the earlier cases, and recently surgery has been largely replaced by medical therapy for treatment of gastric MALToma. 17,18 In conclusion, characteristics abnormal vascular pattern and absence of gastric pits on magnifying endoscopy served as potential features to diagnose gastric MALToma. These features could potentially apply to improve diagnostic accuracy and observe for therapeutic response in patients with gastric MALToma after eradication of H pylori and chemotherapy.…”
Section: Maltoma Was First Described By Isaacson and Wright In 1983mentioning
confidence: 88%